Stomach Ulcer: Clinical Trials

114 trials for Stomach Ulcer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

80 completed, 13 unknown, 9 recruiting, 6 terminated. 43 Phase 3, 18 Not applicable, 15 Phase 4, 11 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 343Completed 38, Terminated 2, Unknown 2, Not yet recruiting 1
Not applicable18Completed 7, Unknown 7, Recruiting 4
Phase 415Completed 8, Not yet recruiting 2, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 111Completed 10, Recruiting 1
Phase 28Completed 6, Unknown 1, Withdrawn 1

Follow Stomach Ulcer: new trials by email Literature Review of Stomach Ulcer trials Research Report on Stomach Ulcer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer
DWP14012 40mg (Fexuprazan), Lansoprazole 30mg - Gastric Ulcer
Phase 3Not yet recruitingDaewoong Pharmaceutical Co. LTD.3842026-10-152026-07-28
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
Esomeprazole (Intravenous), Esomeprazole (Oral), Sucralfate Suspension - Early Gastric Cancer, Gastric Dysplasia
Phase 4Not yet recruitingLanZhou University1202026-04-202026-03-23
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
AD-115A, AD-1151 - Gastric Ulcer
Phase 1RecruitingAddpharma Inc.462026-01-272026-02-11
A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Collect epidemiological, diagnostic, and follow-up data after MCG examination. - Gastritis, Gastric Dysplasia
RecruitingNanfang Hospital, Southern Medical University100002025-06-242025-07-04
The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
AD-115A, AD-1151 - Gastric Ulcer
Phase 1CompletedAddpharma Inc.462025-03-212025-10-03
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
Low Thermal Plasma (LTP) Treatment, Standard of Care Ulcer Treatment (typically PPI Administration) - Roux-en-y Anastomosis Site, Marginal Ulcer
Not applicableRecruitingChristopher C. Thompson, MD, MSc1002025-03-042026-06-25
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
AI-integrated Capsule Gastroscopy (ACG) examination, Electronic gastroduodenoscopy (EGD) examination - Gastric Lesion, Gastritis
Not applicableRecruitingNanfang Hospital, Southern Medical University4822025-03-032025-07-09
Ulcer Pomegranate Muffins
WHOLE WHEAT MUFFIN, 1.5g enriched pomegranate muffins, 3g enriched pomegranate muffins - Gastric, Peptic Ulcer
Not applicableCompletedUniversity of Lahore822024-08-102025-08-19
Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection
Vonoprazan, Esomeprazole - Ulcers, Gastric
Phase 4Not yet recruitingShicai Ye1962024-08-012024-07-29
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
Enteric-coated aspirin, Plain aspirin, Hybrid strategy - Atherosclerotic Cardiovascular Disease, Coronary Artery Disease
Not applicableRecruitingRajaie Cardiovascular Medical and Research Center30002024-03-062025-03-19
Functional Food Product
pomegranate peel powder 1.5 g, pomegranate peel powder 3 g, Whole wheat muffin - Ulcer, Blood Tests
Not applicableCompletedUniversity of Lahore882024-02-152026-08-27
The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass
upper endoscopy - Obesity, Gastric Reflux
Phase 4RecruitingProf Urs Zingg502023-11-012026-06-09
Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.
Vonoprazan Test 20mg, Vonoprazan Reference 20mg - Gastric Ulcer
Phase 1CompletedHanlim Pharm. Co., Ltd.302023-10-232024-10-16
A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
HIP0612, HPP2202, RLD2204 - Gastric Ulcer
Phase 3CompletedHanmi Pharmaceutical Company Limited1992023-03-062025-02-19
The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.
Indocyanine green, Stryker 1688 AIM system - Ulcer, Gastric, Obesity, Morbid
Phase 4Active not recruitingUniversity Health Network, Toronto3002023-01-252025-10-16
Systems Biology of Gastrointestinal and Related Diseases
Ulcerative Colitis, Crohn Disease
TerminatedViome172022-11-112023-12-15
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
JP-1366 20mg, Lansoprazole 30mg - Gastric Ulcer
Phase 3CompletedOnconic Therapeutics Inc.3292022-09-192024-08-26
Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.
ciprofol - Gastric Cancer, Gastric Ulcer
Not applicableUnknownRenJi Hospital302022-09-192023-08-16
Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients
Ciprofol, Propofol - Gastric Ulcer, Gastric Cancer
Phase 4CompletedRenJi Hospital10902022-09-082024-06-07
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
No Interventions - Cancer Diagnosis, Liver Cancer, Adult
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine6002022-09-012025-04-24

Showing 20 of 114. Sign in to see all of them.

Narrower conditions

Duodenal Ulcer (43)  ·  Stomach Neoplasms (17)  ·  Gastritis (12)  ·  Peptic Ulcer (9)  ·  Gastroesophageal Reflux (7)  ·  Osteoarthritis (7)  ·  Arthritis, Rheumatoid (6)  ·  Esophagitis, Peptic (6)  ·  Abdominal Pain (5)  ·  Gastrointestinal Hemorrhage (5)  ·  Nausea (4)  ·  Obesity (4)  ·  Dyspepsia (3)  ·  Gastrointestinal Diseases (3)

Broader conditions

Digestive System Diseases (114)  ·  Duodenal Diseases (114)  ·  Intestinal Diseases (114)  ·  Stomach Diseases (112)  ·  Gastrointestinal Diseases (111)  ·  Peptic Ulcer (105)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Gastroenteritis (23)  ·  Digestive System Neoplasms (20)  ·  Gastrointestinal Neoplasms (20)  ·  Neoplasms (19)  ·  Signs and Symptoms (18)  ·  Neoplasms by Site (17)  ·  Esophageal Diseases (15)  ·  Pathologic Processes (11)

Interventions

Esomeprazole (16)  ·  Lansoprazole (16)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (10)  ·  Naproxen (7)  ·  Rabeprazole (7)  ·  Omeprazole (6)  ·  rebamipide (5)  ·  Amoxicillin (4)  ·  Clarithromycin (3)  ·  Ranitidine (3)  ·  (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (2)  ·  Celecoxib (2)  ·  Clopidogrel (2)  ·  Gastroscopy (2)  ·  Gefarnate (2)

Sponsors

AstraZeneca (17)  ·  Takeda (14)  ·  POZEN (8)  ·  Eisai Co., Ltd. (5)  ·  Hamamatsu University (4)  ·  Nanfang Hospital, Southern Medical University (3)  ·  RenJi Hospital (3)  ·  Addpharma Inc. (2)  ·  Christopher C. Thompson, MD, MSc (2)  ·  DiaSorin Inc. (2)  ·  George Washington University (2)  ·  The Catholic University of Korea (2)  ·  University of Lahore (2)  ·  Ajou University School of Medicine (1)  ·  Anhui Medical University (1)

Countries

Japan (29)  ·  United States (21)  ·  South Korea (20)  ·  China (18)  ·  Taiwan (5)  ·  Italy (4)  ·  Canada (3)  ·  Pakistan (3)  ·  Hong Kong (2)  ·  Indonesia (2)  ·  Philippines (2)  ·  Russia (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Australia (1)

Top investigators

Everardus Orlemans, PhD (4)  ·  Paula Fernstrom (4)  ·  Shigeru Yoshida, MD (4)  ·  Christopher C. Thompson, MD, MSc (2)  ·  Diansan Su (2)  ·  Naotsugu Oyama (2)  ·  Nobuyuki Sugisaki (2)  ·  Allan Okrainec (1)  ·  Andrew C Meltzer, MD, MS (1)  ·  Angelo Zullo, MD (1)  ·  Anita Kumar, MD (1)  ·  Anshuman Sharma, MD (1)  ·  Arbi Ben Abdallah, PhD (1)

Results publications

PMID 28988197, PMID 29196436, PMID 12641522, PMID 17916545, PMID 20230209, PMID 21319944, PMID 21415072, PMID 21726257, PMID 22281110, PMID 22464259, PMID 22591121, PMID 23188121, PMID 23333143, PMID 23462808, PMID 23530709, PMID 24326741, PMID 24714327, PMID 25574111, PMID 25869737, PMID 26418126, PMID 26725920, PMID 27028469, PMID 27211503, PMID 27397702, PMID 27891632, PMID 28378544, PMID 31483889, PMID 32348007, PMID 34197702, PMID 35568242, PMID 35961376, PMID 36342574, PMID 38238541, PMID 38424039, PMID 39085080, PMID 41361300, PMID 41540828, PMID 41626789

NIH funding

2018 (1)